Purchase Order 75N95020P00604
- Not listed
- The National Center for Advancing Translational Sciences, a component of the U.S. Department of Health and Human Services' National Institutes of Health, awarded a $22,226.00 firm fixed price purchase order to MedChemExpress LLC, a New Jersey-based provider of life science research materials. The contract is to obtain 5-milligram samples of biologically active small molecules with well-defined mechanisms of action. This material will be used to create the MIPE 5.1 molecular library, a collection...
- The federal contract award HHSN271201500037A, valued at $498,000.00, was issued by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services (HHS). The contract was awarded to Chemdiv, Inc., a for-profit organization based in San Diego, California, to provide small molecule compounds to support the National Center for Advancing Translational Sciences (NCATS) Pharmacologically Active Chemical Toolbox...
- This $15,735 firm fixed-price purchase order was awarded by the National Institute of Dental and Craniofacial Research (NIDCR), a component of the National Institutes of Health (NIH), to MedChemExpress LLC, a New Jersey-based provider of chemical compounds and research materials. The contract is for chemical synthesis services to produce one chemical probe compound for delivery to NIDCR. No set-aside designation was used. MedChemExpress has previously served as both a prime contractor and...
- This is a $115,000.00 firm fixed price purchase order contract awarded by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH), to Wuxi Apptec (Hongkong) LIMITED, a global contract research and development organization. The contract is for the provision of chemical compounds, small molecule compound libraries, analogues, and other materials to support NIDA's research activities, which may include testing anti-cancer drug candidates, lowering...
- This is a $96,900.00 firm-fixed-price purchase order contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to Edelris, a for-profit manufacturer, for a chemical library of 2,550 small molecule compounds distributed across specified chemical scaffolds. The contract has an ultimate completion date of October 15, 2019. The requirement was originally posted as an open solicitation and there was no set-aside designation. The chemical library will be used by NIDA's...
- This is a $376,706 firm fixed-price purchase order contract awarded by the National Center for Advancing Translational Sciences (NCATS), a component of the U.S. Department of Health and Human Services, to MedChemExpress LLC, a small disadvantaged business located in New Jersey. The contract supports the SMALL MOLECULES FOR NCATS PHARMACOLOGICALLY ACTIVE CHEMICAL TOOLBOX (NPACT) program, providing chemical compounds and other scientific inputs for the agency's biomedical research initiatives....
- Medchemexpress LLC has been awarded a $18,365 firm fixed price purchase order by the Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences to support the development of cap-dependent endonuclease inhibitors for bunyaviruses. Per the award description, Medchemexpress will provide chemical compounds and research materials to support the agency's biomedical research program aimed at developing inhibitors for this class of...
- This federal contract award, identified as 75N95018P00712, was made by the National Institute on Drug Abuse (NIDA), a civilian agency, to Molport SIA, a for-profit limited liability company located in Latvia. The contract, valued at $51,771.73, is for the purchase of a Chemical Library of 216 small molecule compounds. The contract is a firm fixed-price purchase order with an ultimate completion date of January 31, 2019. The contract was awarded on September 20, 2018, following a pre-solicitation...
- The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences awarded a $29,820 firm fixed price purchase order to Medchemexpress LLC to deliver forty-four bioactive compounds for replenishment and expansion of the Mechanism Interrogation PlatE 6.0 screening library. The compounds will support the Center's high-capacity robotic platform used to screen drug combinations and further its chemogenomic screening capabilities. Delivery...
- This federal contract award was made by the National Center for Advancing Translational Sciences (NCATS), a component of the U.S. Department of Health and Human Services, to MedChemExpress LLC, a small disadvantaged business based in New Jersey. The $84,954 firm-fixed-price purchase order is for the provision of small molecules to support NCATS' Pharmacologically Active Chemical Toolbox (NPACT) program, which focuses on developing and evaluating chemical compounds for biomedical research. The...
This federal contract award is for the delivery of a small molecules screening library to the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services. The $23,095 firm fixed-price purchase order was awarded to Medchemexpress LLC, a foreign-owned, minority-owned, and self-certified small disadvantaged business based in New Jersey. The contract does not have a set-aside designation. The award is to administratively de-obligate unexpended and expiring FY 2020 funding in preparation for the September 30, 2025 closing of the period of availability for these funds, as required by 31 U.S.C. Section 1552(a). Medchemexpress has previously supported various NIH components, including the National Center for Advancing Translational Sciences (NCATS), with chemical library development, compound synthesis, and other specialized research services.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00002 | Funding Only Action | ($1k) | 9/15/25 | |
| P00001 | Other Administrative Action | $0 | 6/7/22 | |
| Not listed | Not listed | $24.4k | 9/16/20 |